Pilot Study of Zoledronic Acid and Interleukin-2 for Refractory Pediatric Neuroblastoma
Condition(s):NeuroblastomaLast Updated:December 2, 2014Terminated
Hide Studies Not Open or Pending
Condition(s):NeuroblastomaLast Updated:December 2, 2014Terminated
Condition(s):Retinitis PigmentosaLast Updated:January 18, 2023Active, not recruiting
Condition(s):Squamous Cell Cutaneous Carcinoma of the SkinLast Updated:January 31, 2019Completed
Condition(s):Optic Neuritis; Optic; Neuritis, With DemyelinationLast Updated:April 10, 2019Completed
Condition(s):HIV Infections; Immunologic Deficiency Syndromes; Lymphoproliferative DisordersLast Updated:March 4, 2008Completed
Condition(s):PheochromocytomaLast Updated:July 2, 2017Completed
Condition(s):Last Updated:June 24, 2019Withheld
Condition(s):NeuroblastomaLast Updated:November 4, 2022Terminated
Condition(s):Acne VulgarisLast Updated:March 5, 2018Completed
Condition(s):Hand EczemaLast Updated:February 26, 2019Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.